Pharmaceutical

F. Hoffmann-La Roche gets grant for system for identify...

Discover how F. Hoffmann-La Roche's patented system uses nanopores to identify n...

Incyte gets grant for treatment of various cancers usin...

Discover how Incyte Corp's patent targets adenosine receptors to treat cancer, i...

HCA Healthcare gets grant for wrist brace with advantag...

Discover the innovative wrist brace by HCA Healthcare Inc, featuring a unique la...

United Therapeutics gets grant for treatment of pulmona...

Discover a groundbreaking method for treating pulmonary hypertension with stem c...

Xencor gets grant for bispecific antibody for treating ...

Discover Xencor Inc's groundbreaking patent for novel GPC3 binding domains and b...

Touchlight joins forces with University of Liverpool fo...

The vaccines will be developed using Touchlight’s doggybone DNA technology, whic...

Addex spinoff Neurosterix debuts with $63m for developi...

Addex has also sold its preclinical neurological assets and drug discovery platf...

Lipocine gets grant for pharmaceutical composition for ...

Discover Lipocine Inc's innovative patent for bioavailable solid state esters to...

Clinical trials and development services

Download our comprehensive list of leading specialist companies offering clinica...

A proactive, data-driven approach to closing care gaps ...

New research into lipid management is helping close gaps in treating cardiovascu...

MASH revival with over $2.5bn for innovator drug partne...

MASH innovator drugs witnessed an over $2.5bn increase in the total value of par...

Ipsen joins the ADC club with deal worth up to $900m

Ipsen signed a licensing agreement to develop and commercialise Sutro Biopharma’...

Lenmeldy becomes world’s most expensive drug

The gene therapy for MLD, Lenmeldy (also branded as Libmeldy in some markets), h...

Can pharma overcome generative AI’s bias problem?

While the use of generative AI to optimise the practitioner-to-patient relations...

Merz makes a $185m bid for assets from bankrupt Acorda

Merz placed a “stalking horse bid” for Acorda’s Parkinson’s disease and multiple...

Overcoming the added patient burden in DCTs

Using the right translation and accessibility tools can facilitate patient compr...